Skip to content

Cannabis: all studies

Page 145 of 287: studies 1,441 to 1,450 of 2,868, newest first. Back to the cannabis overview

Research

The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample

Schizophrenia Bulletin July 25, 2010 Murat Yücel, Emre Bora, Dan Ian Lubman et al. 256 citations

Cannabis use is highly prevalent among people with schizophrenia, and coupled with impaired cognition, is thought to heighten the risk of illness onset. However, while heavy cannabis use has been associated with cognitive deficits in long-term users, studies among patients with schizophrenia have been contradictory. This article consists of 2 studies. In Study I, a meta-analysis of 10 studies...

Delta-9-Tetrahydrocannabinol Disruption of Time Perception and of Self-Timed Actions

Pharmacopsychiatry July 22, 2010 James Stone, Paul D. Morrison, Judith Nottage et al. 13 citations

We tested the hypothesis that THC disrupts self-timed actions in healthy volunteers, and that this effect is related to self-rated perceptions of time distortion. We found that THC impaired subjective time perception and reduced the rate of button pressing, although the change in the rate of button pressing was more closely related to impaired concentration and intoxication. We conclude that...

DOI: 10.1055/s-0030-1255030 (opens in new tab) Time perception Delta-9-tetrahydrocannabinol Mechanism biology Δ9-tetrahydrocannabinol +2

A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development

Substance Abuse Treatment Prevention and Policy July 8, 2010 Chaturaka Rodrigo, Srina Welgama, Alwis Gunawardana et al. 8 citations

BACKGROUND: Several epidemiological studies have shown that cannabis; the most widely used illegal drug in the world, is associated with schizophrenia spectrum disorders (SSD). AIMS: To assess the characteristics of cannabis use and its association with SSD in a cohort of psychiatrically ill patients and discuss the implications for policy development METHODS: This is a retrospective analytical...

Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.

Journal of Pharmacology and Experimental Therapeutics July 2010 Jennifer L. Stewart, Lance R Mcmahon

Marijuana-dependent individuals report using marijuana to alleviate withdrawal, suggesting that pharmacotherapy of marijuana withdrawal could promote abstinence. To identify potential pharmacotherapies for marijuana withdrawal, this study first characterized rimonabant-induced Delta(9)-tetrahydrocannabinol (Delta(9)-THC) withdrawal in rhesus monkeys by using drug discrimination and directly...

Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence.

Addiction Biology July 2010 Saturnino Spiga, Alessandra Lintas, Michele Migliore et al.

Cannabinoid withdrawal produces a hypofunction of mesencephalic dopamine neurons that impinge upon medium spiny neurons (MSN) of the forebrain. After chronic treatment with two structurally different cannabinoid agonists, Delta(9)-tetrahydrocannabinol and CP55 940 (CP) rats were withdrawn spontaneously and pharmacologically with the CB1 antagonist SR141716A (SR). In these two conditions,...

Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.

Pharmacology, Biochemistry, and Behavior July 2010 Koen B E Böcker, J Gerritsen, Claudine C Hunault et al.

Cannabis intake has been reported to affect cognitive functions such as selective attention. This study addressed the effects of exposure to cannabis with up to 69.4mg Delta(9)-tetrahydrocannabinol (THC) on Event-Related Potentials (ERPs) recorded during a visual selective attention task. Twenty-four participants smoked cannabis cigarettes with four doses of THC on four test days in a...

Phytocannabinoids beyond the Cannabis plant - do they exist?

British Journal of Pharmacology June 1, 2010 Jürg Gertsch, Roger G Pertwee, Vincenzo Di Marzo

It is intriguing that during human cultural evolution man has detected plant natural products that appear to target key protein receptors of important physiological systems rather selectively. Plants containing such secondary metabolites usually belong to unique chemotaxa, induce potent pharmacological effects and have typically been used for recreational and medicinal purposes or as poisons....

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

Pharmacology, Biochemistry, and Behavior June 2010 Abir T. El-Alfy, Kelly Ivey, Keisha Robinson et al.

The antidepressant action of cannabis as well as the interaction between antidepressants and the endocannabinoid system has been reported. This study was conducted to assess the antidepressant-like activity of Delta(9)-THC and other cannabinoids. Cannabinoids were initially evaluated in the mouse tetrad assay to determine doses that do not induce hypothermia or catalepsy. The automated mouse...

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models

British Journal of Pharmacology June 1, 2010 Daniel T Malone, Matthew N Hill, Tiziana Rubino

Cannabis is one of the most widely used illicit drugs among adolescents, and most users first experiment with it in adolescence. Adolescence is a critical phase for brain development, characterized by neuronal maturation and rearrangement processes, such as myelination, synaptic pruning and dendritic plasticity. The endocannabinoid system plays an important role in fundamental brain...

Psychosis reactivity to cannabis use in daily life: an experience sampling study

The British Journal of Psychiatry May 31, 2010 Cécile Henquet, Jim van Os, Rebecca Kuepper et al. 124 citations

BACKGROUND: Little is known about the experiential dynamics of the interaction between cannabis and vulnerability to psychosis. AIMS: To examine the effects of cannabis on psychotic symptoms and mood in patients with psychosis and healthy controls. METHOD: Patients with a psychotic disorder (n = 42) and healthy controls (n = 38) were followed in their daily lives using a structured...